What's New in the U.S. HIV Clinical Guidelines

We walk you through the most recent updates to official guidelines issued by the U.S. Department of Health and Human Services on the treatment and care of people living with HIV.

By Stephen Hicks

Featured

After Pilot, Whitman-Walker Health Establishes Same-Day HIV Treatment Start Program

"We're very much putting the patient in the driver's seat," said Heather Alt, deputy director of nursing with Whitman-Walker. "If folks didn't feel ready, we would not push them to start."

By Kenyon Farrow

Researchers Recommend Screening All People With HIV for Elevated Liver Function Values

Authors of a literature review note the high prevalence of liver disease among people with HIV and recommend a step-by-step approach to management.

By Barbara Jungwirth

Large French Study Examines Neuropsychiatric Side Effects With Integrase Inhibitors

This will likely become the landmark study about the overall rate of neuropsychiatric side effects with this class of medicines over the next several years.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange

Researchers Crave More Data on HIV Care Continuum Programs for Recently Incarcerated People

Sixteen years after the success of Project START for HIV risk reduction, we still don't know what works best for helping people with HIV stay in care after prison.

By Sony Salzman

Native Americans Have HIV Treatment Adherence Rates on Par With Other Groups

Despite rising HIV rates and structural barriers to accessing care, American Indians and Alaska Natives do not have worse clinical outcomes when they're in care.

By Sony Salzman

De-Simplifying Single-Tablet Regimens for HIV Treatment

A Canadian study of this cost-saving approach found high acceptance of de-simplification among people already on a single-tablet regimen, and even higher rates among people who were just initiating single-tablet treatment.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange

Are Integrase Inhibitors Linked to Weight Gain? An Evidence Review

Integrase inhibitors are associated with greater increases in body weight than other antiretrovirals, especially among women and black people. But it's unclear whether these changes are clinically significant.

By Polly Clayden for HIV i-Base

Why Nurses Should Take the HIV Self-Test

People newly diagnosed with HIV must be able to access treatment and support, which could be improved if guided by people who have been taken the test themselves, researchers found.

By Amanda Lee and Mark Hayter for The Conversation

PositiveLinks: Mobile Intervention for People With HIV

Study results of an intervention that includes a custom smartphone app tailored to the needs and preferences of a rural population of people with HIV living in the southern U.S.

By Canadian AIDS Treatment Information Exchange

Doravirine Sets a New Standard for NNRTIs -- but What Role in HIV Treatment Today?

"Since this appears to be a 'best in class' drug, doravirine has enough advantages that it is a useful advance in HIV therapy, if not a transformational one," writes Paul Sax, M.D.

By Paul E. Sax, M.D. for NEJM Journal Watch